# Allogene Therapeutics, Inc.: Form 8-K, filed Jun 22, 2026

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: 8-K
- Filed: 2026-06-22
- Accepted by EDGAR: Jun 22, 2026, 16:05 ET
- Period: 2026-06-18
- Accession: 0001628280-26-044618
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000162828026044618/allo-20260618.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000162828026044618/

## Items reported

- Item 5.07: Shareholder vote results
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000162828026044618/allo-20260618.htm

Filed Jun 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-044618. Last ingested by Listed: Oct 27, 2026, 17:28 ET. No prices; not investment advice.